The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes
Open accessAbstract
Detection of somatic mutations in human leukocyte antigen (HLA) genes using whole-exome sequencing (WES) is hampered by the high polymorphism of the HLA loci, which prevents alignment of sequencing reads to the human reference genome. We describe a computational pipeline that enables accurate inference of germline alleles of class I HLA-A, B and C genes and subsequent detection of mutations in these genes using the inferred alleles as a reference. Analysis of WES data from 7,930 pairs of tumor and healthy tissue from the same patient revealed 298 nonsilent HLA mutations in tumors from 266 patients. These 298 mutations are enriched for likely functional mutations, including putative loss-of-function events. Recurrence of mutations suggested that these 'hotspot' sites were positively selected. Cancers with recurrent somatic HLA mutations were associated with upregulation of signatures of cytolytic activity characteristic of tumor infiltration by effector lymphocytes, supporting immune evasion by altered HLA function as a contributory mechanism in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
Self-citationThe blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Comprehensive molecular characterization of gastric adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13480 · Cited by 6,498
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Cibulskis, K., Lawrence, M. S., Carter, S. L., Sivachenko, A., Jaffe, D., Sougnez, C., Gabriel, S., Meyerson, M., Lander, E. S., & Getz, G. (2013) · Nature Biotechnology · doi:10.1038/nbt.2514 · Cited by 4,981
Self-citationComprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Molecular and genetic properties of tumors associated with local immune cytolytic activity
Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G., & Hacohen, N. (2015) · Cell · doi:10.1016/j.cell.2014.12.033 · Cited by 3,825
Self-citationDiscovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096
Self-citationA landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610
Self-citationThe Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Stransky, N., Egloff, A. M., Tward, A. D., Kostic, A. D., Cibulskis, K., Sivachenko, A., Kryukov, G. V., Lawrence, M. S., Sougnez, C., McKenna, A., et al. (2011) · Science · doi:10.1126/science.1208130 · Cited by 2,504
Self-citationRegulatory T cells, tumour immunity and immunotherapy
Zou, W. (2006) · Nature Reviews Immunology · doi:10.1038/nri1806 · Cited by 2,085
Strelka: accurate somatic small-variant calling from sequenced tumor–normal sample pairs
Saunders, C. T., Wong, W. S. W., Swamy, S., Becq, J., Murray, L. J., & Cheetham, R. K. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts271 · Cited by 1,635
A polygenic burden of rare disruptive mutations in schizophrenia
Purcell, S. M., Moran, J. L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., O’Dushlaine, C., Chambert, K., Bergen, S. E., Kähler, A., et al. (2014) · Nature · doi:10.1038/nature12975 · Cited by 1,385
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia
Landau, D. A., Carter, S. L., Stojanov, P., McKenna, A., Stevenson, K., Lawrence, M. S., Sougnez, C., Stewart, C., Sivachenko, A., Wang, L., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.019 · Cited by 1,379
Self-citationAntigen Recognition by Class I-Restricted T Lymphocytes
Townsend, A., & Bodmer, H. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.003125 · Cited by 1,198
SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
Wang, L., Lawrence, M. S., Wan, Y., Stojanov, P., Sougnez, C., Stevenson, K., Werner, L., Sivachenko, A., DeLuca, D. S., Zhang, L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1109016 · Cited by 1,080
Self-citationComplete sequence and gene map of a human major histocompatibility complex
The MHC sequencing consortium (1999) · Nature · doi:10.1038/44853 · Cited by 1,065
Lohr, J. G., Stojanov, P., Lawrence, M. S., Auclair, D., Chapuy, B., Sougnez, C., Cruz-Gordillo, P., Knoechel, B., Asmann, Y. W., Slager, S. L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121343109 · Cited by 974
Self-citationOptiType: precision HLA typing from next-generation sequencing data
Szolek, A., Schubert, B., Mohr, C., Sturm, M., Feldhahn, M., & Kohlbacher, O. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu548 · Cited by 769
Gonzalez-Galarza, F. F., Christmas, S., Middleton, D., & Jones, A. R. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1128 · Cited by 724
STRUCTURE, FUNCTION, AND DIVERSITY OF CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULES
Bjorkman, P. J., & Parham, P. (1990) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.59.070190.001345 · Cited by 700
Robinson, J., Waller, M. J., Fail, S. C., McWilliam, H., Lopez, R., Parham, P., & Marsh, S. G. E. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn662 · Cited by 700
Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules
Ruppert, J., Sidney, J., Celis, E., Kubo, R. T., Grey, H. M., & Sette, A. (1993) · Cell · doi:10.1016/0092-8674(93)90472-3 · Cited by 628
Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival
Brown, S. D., Warren, R. L., Gibb, E. A., Martin, S. D., Spinelli, J. J., Nelson, B. H., & Holt, R. A. (2014) · Genome Research · doi:10.1101/gr.165985.113 · Cited by 594
The advantages of SMRT sequencing
Roberts, R. J., Carneiro, M. O., & Schatz, M. C. (2013) · Genome Biology · doi:10.1186/gb-2013-14-6-405 · Cited by 584
Robinson, J., Halliwell, J. A., McWilliam, H., Lopez, R., Parham, P., & Marsh, S. G. E. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks949 · Cited by 550
Systematic evaluation of spliced alignment programs for RNA-seq data
The RGASP Consortium, Engström, P. G., Steijger, T., Sipos, B., Grant, G. R., Kahles, A., Rätsch, G., Goldman, N., Hubbard, T. J., Harrow, J., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2722 · Cited by 513
The advantages of SMRT sequencing
Roberts, R. J., Carneiro, M. O., & Schatz, M. C. (2013) · Genome biology · doi:10.1186/gb-2013-14-7-405 · Cited by 454
HLA typing from RNA-Seq sequence reads
Boegel, S., Löwer, M., Schäfer, M., Bukur, T., de Graaf, J., Boisguérin, V., Türeci, Ö., Diken, M., Castle, J. C., & Sahin, U. (2012) · Genome Medicine · doi:10.1186/gm403 · Cited by 270
Derivation of HLA types from shotgun sequence datasets
Warren, R. L., Choe, G., Freeman, D. J., Castellarin, M., Munro, S., Moore, R., & Holt, R. A. (2012) · Genome Medicine · doi:10.1186/gm396 · Cited by 192
Origin of Spliceosomal Introns and Alternative SplicingPreprint
Irimia, M., & Roy, S. W. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016071 · Cited by 187
High-throughput, high-fidelity HLA genotyping with deep sequencing
Wang, C., Krishnakumar, S., Wilhelmy, J., Babrzadeh, F., Stepanyan, L., Su, L. F., Levinson, D., Fernandez-Viña, M. A., Davis, R. W., Davis, M. M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206614109 · Cited by 183
MHC class I down-regulation: tumour escape from immune surveillance? (Review)
Bubeník, J. (2004) · International Journal of Oncology · doi:10.3892/ijo.25.2.487 · Cited by 167
Next-generation sequencing for HLA typing of class I loci
Erlich, R., Jia, X., Anderson, S. T., Banks, E., Gao, X., Carrington, M. N., Gupta, N., DePristo, M. A., Henn, M. R., Lennon, N. J., et al. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-42 · Cited by 143
Inference of high resolution HLA types using genome-wide RNA or DNA sequencing reads
Bai, Y., Ni, M., Cooper, B., Wei, Y., & Fury, W. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-325 · Cited by 134
Multiple mechanisms underlie HLA dysregulation in cervical cancer
Brady, C. S., Bartholomew, J. S., Burt, D. J., Duggan-Keen, M. F., Glenville, S., Telford, N., Little, A., Davidson, J. A., Jiménez, P., Ruiz‐Cabello, F., et al. (2000) · Tissue Antigens · doi:10.1034/j.1399-0039.2000.550502.x · Cited by 128
Omberg, L., Ellrott, K., Yuan, Y., Kandoth, C., Wong, C., Kellen, M., Friend, S. H., Stuart, J. M., Liang, H., & Margolin, A. A. (2013) · Nature Genetics · doi:10.1038/ng.2761 · Cited by 114
Prediction of promiscuous peptides that bind HLA class I molecules
Brusić, V., Petrovsky, N., Zhang, G., & Bajić, V. B. (2002) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2002.01088.x · Cited by 95
DNA typing for HLA class I alleles: I. Subsets of HLA-A2 and of -A28
Fernández-Viña, M., Falco, M., Sun, Y., & Šťastný, P. (1992) · Human Immunology · doi:10.1016/0198-8859(92)90068-x · Cited by 82
Cao, H., Wu, J., Wang, Y., Jiang, H., Zhang, T., Liu, X., Xu, Y., Liang, D., Gao, P., Sun, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069388 · Cited by 64
HLA Haplotyping from RNA-seq Data Using Hierarchical Read Weighting
Kim, H. J., & Pourmand, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067885 · Cited by 64
Pittet, M. J., Rubio‐Godoy, V., Bioley, G., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.1844 · Cited by 58
Tiercy, J., Djavad, N., Rufer, N., et al. (1994) · Human Immunology · doi:10.1016/0198-8859(94)90038-8 · Cited by 55
Lank, S. M., Golbach, B. A., Creager, H. M., Wiseman, R. W., Keskin, D. B., Reinherz, E. L., Brusić, V., & O’Connor, D. H. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-378 · Cited by 36
Jiménez, P., Cabrera, T., Méndez, R., Esparza, C., Cozar, J. M., Tallada, M., López‐Nevot, M. Á., Ruiz‐Cabello, F., & Garrido, F. (2001) · Immunogenetics · doi:10.1007/s002510100371 · Cited by 27
Cited by
The Immune Landscape of Cancer
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Ou Yang, T.-H., Porta-Pardo, E., Gao, G. F., Plaisier, C. L., Eddy, J. A., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.023 · Cited by 5,870
Self-citationClonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
McGranahan, N., Furness, A. J. S., Rosenthal, R., Ramskov, S., Lyngaa, R., Saini, S. K., Jamal-Hanjani, M., Wilson, G. A., Birkbak, N. J., Hiley, C. T., et al. (2016) · Science · doi:10.1126/science.aaf1490 · Cited by 3,065
Self-citationComprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
Robertson, A. G., Kim, J., Al-Ahmadie, H., Bellmunt, J., Guo, G., Cherniack, A. D., Hinoue, T., Laird, P. W., Hoadley, K. A., Akbani, R., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.007 · Cited by 2,443
Self-citationThe evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Havel, J. J., Chowell, D., & Chan, T. A. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0116-x · Cited by 2,286
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion
Jhunjhunwala, S., Hammer, C., & Delamarre, L. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00339-z · Cited by 1,490
Metadata
- Authors
- Shukla, S. A., Rooney, M. S., Rajasagi, M., Tiao, G., Dixon, P. M., Lawrence, M. S., Stevens, J., Lane, W. J., Dellagatta, J. L., Steelman, S., Sougnez, C., Cibulskis, K., Kiezun, A., Hacohen, N., Brusic, V., Wu, C. J., & Getz, G.
- Venue
- Nature Biotechnology
- Published
- 2015-09-15
- Volume
- 33
- Issue
- 11
- Pages
- 1152-1158
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2214699570
- Cited by
- 675
- References
- 46
- FWCI
- 15.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.